Norwegian version
Ane Gedde-Dahl

Ane Gedde-Dahl

Scientific publications

Aas, Vigdis; Gedde-Dahl, Ane; Tingstad, Ragna Husby; Charnock, Colin (2015). Tarmfloraen - på helsa løs. Norsk Farmaceutisk Tidsskrift . Vol. 123.

Gedde-Dahl, Ane; Devold, Helene Margrethe; Molden, Espen (2012). Statin medication in patients treated with antiepileptic drugs in Norway. Pharmacoepidemiology and Drug Safety . Vol. 21.

Skottheim, Ine Blankenberg; Gedde-Dahl, Ane; Hejazifar, Solmaz; Hoel, Kjersti; Åsberg, Anders; Åsberg, Anders (2008). Statin induced myotoxicity: The lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. European Journal of Pharmaceutical Sciences . Vol. 33.

Gedde-Dahl, Ane; Harg, Pernille; Stenberg-Nilsen, Hanne; Buajordet, Marit; Granas, Anne G.; Horn, Anne M. (2007). Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiology and Drug Safety . Vol. 16.

Waage, Inger Marie; Gedde-Dahl, Ane (2003). Olanzapine possibly associated with pulmonary embolism. BMJ. British Medical Journal . Vol. 327.

Gedde-Dahl, Ane; Kulseth, M. A.; Ranheim, Trine; Drevon, Christian A; Rustan, Arild (2002). Reduced secretion of triacylglycerol in CaCo-2 cells transfected with intestinal fatty acid-binding protein. Lipids . Vol. 37.

Schjøtt, Jan; Pomp, Erik; Gedde-Dahl, Ane (2002). Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?. European Journal of Clinical Pharmacology . Vol. 57.

These publications are obtained from Cristin. The list may be incomplete